Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00117481 · ClinicalTrials.gov registry record · Phase 2
Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain
A Phase 2 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT00117481 is a Phase 2 study that has completed, run by Duramed Research. The registered enrollment target is 90 participants.
The verdict
NCT00117481, a Phase 2 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
This is a 3-arm, multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy of DR-2001 in endometriosis-related symptoms, primarily nonmenstrual pelvic pain, over a 12-week treatment period.
Interventions
- OTHER Placebo
- DRUG DR-2001a
- DRUG DR-2001b
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00117481
The ClinicalTrials.gov registry entry for NCT00117481 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duramed Research, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00117481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00117481 about?
NCT00117481 is a clinical study titled "Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain". This is a 3-arm, multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy of DR-2001 in endometriosis-related symptoms, primarily nonmenstrual pelvic pain, over a 12-week treatment period.
What is the current status of trial NCT00117481?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2005-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00117481?
The interventions under investigation include: Placebo (OTHER), DR-2001a (DRUG), DR-2001b (DRUG).
Who is sponsoring clinical trial NCT00117481?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.